Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan

被引:16
作者
Saghari, Mohsen [1 ]
Gholamrezanezhad, Ali [1 ]
Mirpour, Sahar [1 ]
Eftekhari, Mohammad [1 ]
Takavar, Abbas [1 ]
Fard-Esfahani, Armaghan [1 ]
Fallahi, Babak [1 ]
Beiki, Davood [1 ]
机构
[1] Univ Tehran, Res Inst Nucl Med, Tehran 14114, Iran
关键词
differentiated thyroid carcinoma; thyroglobulin; whole-body scanning;
D O I
10.1097/00006231-200607000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction In the management of patients with differentiated thyroid carcinoma, serum thyroglobulin levels are often well correlated with whole-body radioiodine scanning (WBS) results. However, occasionally, a mismatched result - increased thyroglobulin with negative WBS - is observed. Radioiodine therapy has been suggested as a therapeutic choice with controversial results. Method We studied 32 differentiated thyroid carcinoma patients with elevated thyroglobulin level and negative WBS who had been treated with high-dose radioiodine. With a mean follow-up of 25.6 months (all follow-ups > 11 months), thyroglobulin and thyroid-stimulating hormone levels, WBS, clinical, radiographic and pathological findings following treatment were recorded. Results The mean pre-therapy off-treatment thyroglobulin was 152 +/- 119.0 ng (.) ml(-1). Although there was a mild trend towards an increase in thyroglobulin in the first post-treatment year, the difference was not significant. At the end of the follow-ups, 22 patients (68.7%) were categorized as non-responders to radioiodine therapy (any change or elevation of thyroglobulin or radiological and pathological evidences of progression), four patients (12.5%) as partial responders (transient reduction but not a normalization of thyroglobulin) and six patients (18.7%) as responders (normalization of thyroglobulin with no evidence of remnant disease). In nine of 10 partial and complete responders, reduction or normalization of thyroglobulin had occurred in the first post-treatment year. Conclusion We recommend that in differentiated thyroid carcinoma patients with elevated thyroglobulin and negative WBS, at least one course of radioiodine therapy should be undertaken and if reduction or normalization of serum thyroglobulin is not achieved, repeated courses of radioiodine therapy are not logical and other therapeutic methods should be applied.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 26 条
[1]   Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer [J].
Alzahrani, AS ;
Raef, H ;
Sultan, A ;
Al Sobhi, S ;
Ingemansson, S ;
Ahmed, M ;
Al Mahfouz, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (06) :526-531
[2]   THE COMPARATIVE VALUE OF SERUM THYROGLOBULIN MEASUREMENTS AND I-131 TOTAL-BODY SCANS IN THE FOLLOW-UP-STUDY OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J].
ASHCRAFT, MW ;
VANHERLE, AJ .
AMERICAN JOURNAL OF MEDICINE, 1981, 71 (05) :806-814
[3]  
Caplan Robert H, 2005, Endocr Pract, V11, P43
[4]   SERUM THYROGLOBULIN LEVELS PREDICT TOTAL-BODY IODINE SCAN FINDINGS IN PATIENTS WITH TREATED WELL-DIFFERENTIATED THYROID-CARCINOMA [J].
CHARLES, MA ;
DODSON, LE ;
WALDECK, N ;
HOFELDT, F ;
GHAED, N ;
TELEPAK, R ;
OWNBEY, J ;
BURSTEIN, P .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (03) :401-407
[5]   Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin [J].
de Keizer, B ;
Koppeschaar, HPF ;
Zelissen, PMJ ;
Lips, GJM ;
van Rijk, PP ;
van Dijk, A ;
de Kerk, JMH .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (02) :198-202
[6]   Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: Including comments on the role of serum thyroglobulin monitoring in tumor surveillance [J].
Fatourechi, V ;
Hay, ID .
SEMINARS IN NUCLEAR MEDICINE, 2000, 30 (02) :107-114
[7]   Lack of impact of radioiodine therapy in Tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer [J].
Fatourechi, V ;
Hay, ID ;
Javedan, H ;
Wiseman, GA ;
Mullan, BP ;
Gorman, CA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1521-1526
[8]   A COMPARISON OF SERUM THYROGLOBULIN MEASUREMENTS AND WHOLE-BODY I-131 SCANNING IN THE MANAGEMENT OF TREATED DIFFERENTIATED THYROID-CARCINOMA [J].
GALLIGAN, JP ;
WINSHIP, J ;
VANDOORN, T ;
MORTIMER, RH .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (04) :248-254
[9]   I-131 therapy for thyroglobulin positive patients without anatomical evidence of persistent disease [J].
Kamel, N ;
Çorapcioglu, D ;
Sahin, M ;
Gürsoy, A ;
Küçük, Ö ;
Aras, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2004, 27 (10) :949-953
[10]   Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan:: comparative study [J].
Koh, JM ;
Kim, ES ;
Ryu, JS ;
Hong, SJ ;
Kim, WB ;
Shong, YK .
CLINICAL ENDOCRINOLOGY, 2003, 58 (04) :421-427